The world’s leading manufacturer of DNA sequencing systems will pay $9.8 million to resolve allegations that it knowingly sold products with security vulnerabilities to federal agencies, Rhode ...

Illumina Inc., a leading biotechnology company, has agreed to pay $9.8 million to settle allegations that it sold genomic ...

First announced at the Illumina Genomics Forum last September, NovaSeq X offers high-throughput sequencing that is twice as fast and three times as accurate as previous Illumina products. It can ...

Illumina posted revenues of $859m in Q120 - up 1.5% year on year, and bottom-line profits of $173m - a year-on-year decrease of 23%, whilst net profit margins also fell to just over 20%.

Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, ...

Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now available to ...

Illumina Accelerator will collaborate with Helix to support startups building direct-to-consumer genomics products. Illumina Accelerator, which is accepting applications for its seventh funding ...

The case is Zirvi v. Illumina Inc, U.S. District Court for the District of New Jersey, No. 2:23-cv-01997. For Monib Zirvi: Joseph Garrity of Lorium Law; and Ahmed Soliman of Soliman & Associates ...

The companies plan to join forces to set up pathogen monitoring programs utilizing Illumina technology across Concentric's global network. BOSTON and SAN DIEGO, Jan. 15, 2024/ PRNewswire ...

Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive.

Illumina and Grail recently passed another one-year anniversary: the launch of the latter's Galleri screening test, designed to detect the evidence of as many as 50 different cancers from a single ...

BASEL (Reuters) - Swiss drugmaker Roche Holding AG , bidding $5.7 billion for U.S. gene sequencing company Illumina , pinned its hopes on new products to drive growth this year after reporting a 4 ...